192 related articles for article (PubMed ID: 267309)
1. A hemophilia home care program utilizing cryoprecipitate.
Shanberge JN; Kratz NL; Aster RH
Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
[No Abstract] [Full Text] [Related]
2. Impact of hemophilia home therapy program on a regional blood center.
Lello CJ; Lazerson J; Kreuger D
Wis Med J; 1980 Oct; 79(10):36-8. PubMed ID: 6779429
[No Abstract] [Full Text] [Related]
3. Dose requirement for replacement therapy in hemophilia A.
Allain JP
Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
[TBL] [Abstract][Full Text] [Related]
4. Cryoprecipitate.
Armstrong D
S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
[No Abstract] [Full Text] [Related]
5. Home transfusion for patients with hemophilia A.
Rabiner SF; Telfer MC
N Engl J Med; 1970 Nov; 283(19):1011-5. PubMed ID: 5470264
[No Abstract] [Full Text] [Related]
6. Hemophilia home transfusion program: effect of cryoprecipitate utilization.
Lazerson J
J Pediatr; 1973 May; 82(5):857-9. PubMed ID: 4698962
[No Abstract] [Full Text] [Related]
7. A simple and inexpensive device for pooling cryoprecipitate.
Low WT; Gillon R; Jones P
Lancet; 1977 Sep; 2(8039):641. PubMed ID: 71453
[No Abstract] [Full Text] [Related]
8. [Hemophilia: the blood bank's concern?].
Smit Sibinga CT
Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
[No Abstract] [Full Text] [Related]
9. Current therapy for hemophiliacs: home care and therapeutic complications.
Hilgartner MW; Sergis E
Mt Sinai J Med; 1977; 44(3):316-31. PubMed ID: 302396
[No Abstract] [Full Text] [Related]
10. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
Vergoz D; Combrisson A; Vialette T; André R
Transfusion (Paris); 1967; 10(1):3-10. PubMed ID: 6048649
[No Abstract] [Full Text] [Related]
11. Letter: Blood fractions for haemophilia.
Lancet; 1974 Jul; 2(7873):155. PubMed ID: 4135512
[No Abstract] [Full Text] [Related]
12. [Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].
Vlcková M; Vorlová Z
Vnitr Lek; 1980 Nov; 26(11):1101-6. PubMed ID: 6789551
[No Abstract] [Full Text] [Related]
13. A little freedom for the hemophiliac.
Britten AF
N Engl J Med; 1970 Nov; 283(19):1051-2. PubMed ID: 5470269
[No Abstract] [Full Text] [Related]
14. Therapy for AHF and PTC hemophilia. I.
Seeler RA
IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
[No Abstract] [Full Text] [Related]
15. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
Smith KJ; Hodges PA
Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic value of cryoprecipitate in hemophilia A].
Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S
Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749
[No Abstract] [Full Text] [Related]
17. Specific therapy in hemophilia.
Hutaff LW
N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
[No Abstract] [Full Text] [Related]
18. Letter: Use and misuse of cryoprecipitate.
Hensley MJ
N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
[No Abstract] [Full Text] [Related]
19. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
Otto-Servais M; Hugues J
Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
[No Abstract] [Full Text] [Related]
20. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
Lange D; Lazerson J
Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
[No Abstract] [Full Text] [Related]
[Next] [New Search]